Effectiveness of Community-based Interventions for Patients with Schizophrenia Spectrum Disorders: a Study Protocol for a Systematic Review

Overview

Journal Syst Rev

Publisher Biomed Central

Date 2021 Apr 13

PMID 33845902

Citations 2

Authors

Soo-Yeon Kim

Ah Rim Kim

Affiliations

Soon will be listed here.

Abstract

Background: Schizophrenia requires a community-based intervention approach combined with standard treatment to prevent relapses. A literature review is required to understand the effectiveness of community-based interventions and to enhance quality in countries where they have not been fully established. This is a protocol for a systematic review of the effectiveness of community-based interventions for patients with schizophrenia spectrum disorders.

Methods: We will search (from inception to January 2021) PubMed/MEDLINE, EMBASE, PsycINFO, CENTRAL, CINAHL, and Research Information Sharing Service/Korean databases. Randomized controlled trials on community-based interventions for patients with schizophrenia spectrum disorders will be eligible. The comparison groups will include patients with schizophrenia spectrum disorders who are only receiving the usual care and those who also receive community-based interventions. The schizophrenia spectrum disorders referred to in this study are defined according to the DSM-5: delusional disorders, schizophrenic disorders, and schizoaffective disorder will be included. Relapse/re-hospitalization rates (primary outcome) and quality of life (secondary outcome) will be identified for each group. Two reviewers will independently screen study titles, abstract data, and full-text articles and perform the data extraction process. Potential conflicts will be resolved through discussion. The study risk of bias will be appraised using the Cochrane Risk of Bias 2.0 tool. Results will be descriptively synthesized and will be structured according to patients' characteristics, intervention type and exposure, and outcome type. If feasible and appropriate, outcome data will be used to perform random effects meta-analyses. Discrete variables will be calculated via odds ratio, and continuous variables will be calculated via standardized mean difference using RevMan 5.3 software.

Discussion: We will provide a summary of the available evidence on the effectiveness of community-based interventions and specific guidelines to improve their outcomes.

Systematic Review Registration: PROSPERO ( CRD42019145660 ).

Citing Articles

A Comparative Analysis of Neurocognitive Function in Community- and Hospital-Based Patients With Schizophrenia.

Maeng S, Kim H, Lee T, Koo H, Kim W Psychiatry Investig. 2024; 21(10):1110-1119.

PMID: 39465237 PMC: 11513869. DOI: 10.30773/pi.2024.0077.

Quality of life and its influencing factors in patients with schizophrenia.

Lin C, Wan X, Zhang R, Yang X, Liu Y Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023; 48(3):472-480.

PMID: 37164931 PMC: 10930085. DOI: 10.11817/j.issn.1672-7347.2023.220438.

References

Magliano L, Fiorillo A, De Rosa C, Malangone C, Maj M . Family burden in long-term diseases: a comparative study in schizophrenia vs. physical disorders. Soc Sci Med. 2005; 61(2):313-22. DOI: 10.1016/j.socscimed.2004.11.064. View

Carra G, Johnson S, Crocamo C, Angermeyer M, Brugha T, Azorin J . Psychosocial functioning, quality of life and clinical correlates of comorbid alcohol and drug dependence syndromes in people with schizophrenia across Europe. Psychiatry Res. 2016; 239:301-7. DOI: 10.1016/j.psychres.2016.03.038. View

Robinson D, Woerner M, Alvir J, Bilder R, Goldman R, Geisler S . Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999; 56(3):241-7. DOI: 10.1001/archpsyc.56.3.241. View

Heckers S, Barch D, Bustillo J, Gaebel W, Gur R, Malaspina D . Structure of the psychotic disorders classification in DSM-5. Schizophr Res. 2013; 150(1):11-4. DOI: 10.1016/j.schres.2013.04.039. View

Munoz-Negro J, Ibanez-Casas I, de Portugal E, Ochoa S, Dolz M, Haro J . A dimensional comparison between delusional disorder, schizophrenia and schizoaffective disorder. Schizophr Res. 2015; 169(1-3):248-254. DOI: 10.1016/j.schres.2015.10.039. View

Park J, Choi Y, Kim B, Lee D, Gim M . Use of the terms "schizophrenia" and "schizophrenic" in the South Korean news media: a content analysis of newspapers and news programs in the last 10 years. Psychiatry Investig. 2012; 9(1):17-24. PMC: 3285736. DOI: 10.4306/pi.2012.9.1.17. View

Krakowski M, Czobor P, Citrome L, Bark N, Cooper T . Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry. 2006; 63(6):622-9. DOI: 10.1001/archpsyc.63.6.622. View

Armijo J, Mendez E, Morales R, Schilling S, Castro A, Alvarado R . Efficacy of community treatments for schizophrenia and other psychotic disorders: a literature review. Front Psychiatry. 2013; 4:116. PMC: 3793168. DOI: 10.3389/fpsyt.2013.00116. View

Guyatt G, Oxman A, Akl E, Kunz R, Vist G, Brozek J . GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011; 64(4):383-94. DOI: 10.1016/j.jclinepi.2010.04.026. View

10.

Immonen J, Jaaskelainen E, Korpela H, Miettunen J . Age at onset and the outcomes of schizophrenia: A systematic review and meta-analysis. Early Interv Psychiatry. 2017; 11(6):453-460. PMC: 5724698. DOI: 10.1111/eip.12412. View

11.

Kessler T, Lev-Ran S . The association between comorbid psychiatric diagnoses and hospitalization-related factors among individuals with schizophrenia. Compr Psychiatry. 2018; 89:7-15. DOI: 10.1016/j.comppsych.2018.12.004. View

12.

Godbout L, Limoges F, Allard I, Braun C, Stip E . Neuropsychological and activity of daily living script performance in patients with positive or negative schizophrenia. Compr Psychiatry. 2007; 48(3):293-302. DOI: 10.1016/j.comppsych.2007.01.003. View

13.

Correll C, Galling B, Pawar A, Krivko A, Bonetto C, Ruggeri M . Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression. JAMA Psychiatry. 2018; 75(6):555-565. PMC: 6137532. DOI: 10.1001/jamapsychiatry.2018.0623. View

14.

Misiak B, Frydecka D, Beszlej J, Moustafa A, Tybura P, Kucharska-Mazur J . Effects of antipsychotics on insight in schizophrenia: results from independent samples of first-episode and acutely relapsed patients. Int Clin Psychopharmacol. 2016; 31(4):185-91. DOI: 10.1097/YIC.0000000000000120. View

15.

Asher L, Patel V, De Silva M . Community-based psychosocial interventions for people with schizophrenia in low and middle-income countries: systematic review and meta-analysis. BMC Psychiatry. 2017; 17(1):355. PMC: 5661919. DOI: 10.1186/s12888-017-1516-7. View

16.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015; 4:1. PMC: 4320440. DOI: 10.1186/2046-4053-4-1. View

17.

Torrey E . Stigma and violence: isn't it time to connect the dots?. Schizophr Bull. 2011; 37(5):892-6. PMC: 3160234. DOI: 10.1093/schbul/sbr057. View

18.

Naz B, Bromet E, Mojtabai R . Distinguishing between first-admission schizophreniform disorder and schizophrenia. Schizophr Res. 2003; 62(1-2):51-8. DOI: 10.1016/s0920-9964(02)00332-8. View

19.

Chatterjee S, Naik S, John S, Dabholkar H, Balaji M, Koschorke M . Effectiveness of a community-based intervention for people with schizophrenia and their caregivers in India (COPSI): a randomised controlled trial. Lancet. 2014; 383(9926):1385-94. PMC: 4255067. DOI: 10.1016/S0140-6736(13)62629-X. View

20.

Semkovska M, Bedard M, Godbout L, Limoge F, Stip E . Assessment of executive dysfunction during activities of daily living in schizophrenia. Schizophr Res. 2004; 69(2-3):289-300. DOI: 10.1016/j.schres.2003.07.005. View